[1] Wang DW, Hu B, Hu C, Zhu FF, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061 − 9. http://dx.doi.org/10.1001/jama.2020.1585CrossRef
[2] Wong G, Liu WJ, Liu YX, Zhou BP, Bi YH, Gao GF. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe 2015;18(4):398 − 401. http://dx.doi.org/10.1016/j.chom.2015.09.013CrossRef
[3] Zhou F, Yu T, Du RH, Fan GH, Liu Y, Liu ZB, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054 − 62. http://dx.doi.org/10.1016/S0140-6736(20)30566-3CrossRef
[4] Bai Y, Yao LS, Wei T, Tian F, Jin DY, Chen LJ, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020;323(14):1406 − 7. http://dx.doi.org/10.1001/jama.2020.2565CrossRef
[5] Cai J, Sun WJ, Huang JP, Gamber M, Wu J, He GQ. Indirect virus transmission in cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerg Infect Dis 2020;26(6):1343 − 5. http://dx.doi.org/10.3201/eid2606.200412CrossRef